SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
January 19,
2022
Commission
File Number 001-14978
SMITH & NEPHEW
plc
(Registrant's
name)
Building 5, Croxley Park,
Hatters Lane, Watford, Hertfordshire, WD18 8YE,
England
(Address
of registrant's principal executive offices)
[Indicate
by check mark whether the registrant files or will file
annual
reports
under cover Form 20-F or Form 40-F.]
Form
20-F
X
Form 40-F
---
---
[Indicate
by check mark if the registrant is submitting the Form 6-K
in
paper
as permitted by Regulation S-T Rule 101(b)(1).]
Yes
No X
---
---
[Indicate
by check mark if the registrant is submitting the Form 6-K
in
paper
as permitted by Regulation S-T Rule 101(b)(7).]
Yes
No X
---
---
[Indicate
by check mark whether by furnishing the information
contained
in this
Form, the registrant is also thereby furnishing information to
the
Commission
pursuant to Rule 12g3-2 (b) under the Securities Exchange Act
of
1934.]
Yes
No X
---
---
If
"Yes" is marked, indicate below the file number assigned to
the
registrant
in connection with Rule 12g3-2 (b) : 82- n/a.
SMITH & NEPHEW PLC
19 January 2022
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND
PERSONS CLOSELY ASSOCIATED WITH THEM.
On 18 January 2022, Smith & Nephew plc (the "Company") received
notification of the following transactions as detailed
below.
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc SPON ADR American Depositary Shares
(ADS)
|
|
Identification code
|
ISIN: US83175M2052
|
|
Nature of the transaction
|
Purchase of American Depository Shares as participants of the
Company's Employee Stock Purchase Plan
|
|
Date of Transaction
|
2022 - 01 - 13
|
|
Place of Transaction
|
New York Stock Exchange
|
|
Name
(Position)
|
Director / PDMR
|
Price ($)
|
Volume
|
Aggregated information
|
Total Ordinary Share Holding following the transaction
*
|
Total Ordinary Share Holding as a % of the Company's ISC following
the transaction *
|
|
Bradley Cannon
(President Sports Medicine & ENT)
|
PDMR
|
29.43
|
284.93272
|
N/A Single Transaction
|
78,530.17832 (including 2,718.50860 in
ADS')
|
0.00887%
|
|
Alison Parkes
(Chief Compliance Officer)
|
PDMR
|
29.43
|
220.86307
|
N/A Single Transaction
|
1,538.24834 (including 400.24362 in
ADS')
|
0.00017%
|
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
Susan Swabey
Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
Smith
& Nephew Plc
(Registrant)
Date: January
19, 2022
By: /s/
Susan Swabey
-----------------
Susan
Swabey
Company
Secretary